KSC 2018 | 62nd Annual Scientific Meeting of The Korean Society of Cardiology

10:20-10:35
No: 109
[620146]

English Session A prospective survey of the persistence of warfarin or NOAC in nonvalvular atrial fibrillation: A COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF)

[Speaker] Hyeongsoo KIM
Hyeongsoo Kim, MD^1*; Young Soo Lee, MD²; Tae-Hoon Kim, MD¹; Myung-Jin Cha, MD²; Jung Myung Lee, MD³; Junbeom Park, MD⁴; Jin-Kyu Park, MD⁵; Ki-Woon Kang, MD⁶; Jaemin Shim, MD⁷; Jae-Sun Uhm, MD¹; Hyung Wook Park, MD⁹; Eue-Keun Choi, MD²; Jin-Bae Kim, MD³; Changsoo Kim, MD¹⁰; Jun Kim, MD¹¹; Boyoung Joung, MD¹
¹Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul ²Division of Cardiology, Daegu Catholic University Medical Center, Daegu, ³Department of Internal Medicine, Seoul National University Hospital, Seoul ⁴Division of Cardiology, Kyung Hee University Hospital, Kyung Hee University, Seoul ⁵Department of Cardiology, School of Medicine, Ewha Womans University, Seoul

10:35-10:50
No: 110
[620242]

English Session Impact of off-label dosing of non-vitamin K antagonist oral anticoagulants on clinical outcomes in Asian patients with non-valvular atrial fibrillation: from CODE-AF (COmparison study of Drugs for symptom control and complication prEvention of AF) registry

[Speaker] So Ryoung
So-Ryoung Lee¹, Eue-Keun Choi², Myung-Jin Cha², Tae-Hoon Kim³,Junbeom Park⁴, Jin-Kyu Park⁵, Jung-Myung Lee⁶, Ki-Woon Kang⁷, Jaemin Shim⁸, Jae-Sun Uhm³, Jun Kim⁹, Changsoo Kim¹⁰, Jin-Bae Kim⁶, Hyung Wook Park¹¹, Young Soo Lee¹², Boyoung Joung³
¹ Department of Internal Medicine, Soon Chun Hyang University Hospital Seoul, Seoul, Korea ² Department of Internal Medicine Seoul National University Hospital, Seoul, Korea ³ Division of Cardiology, Yonsei University College of Medicine, Seoul, Korea ⁴ Department of Cardiology, College of Medicine, Ewha Womans University, Seoul, Korea ⁵ Division of Cardiology, Hanyang University Medical Center, Seoul, Korea ⁶ Division of Cardiology, Kyung Hee University Medical College, Seoul, Korea ⁷ Division of Cardiology, Eulji University Hospital, Daejeon, Korea ⁸ Division of Cardiology, Korea University Anam Hospital, Seoul, Korea ⁹ Department of Internal Medicine, University of Ulsan College of Medicine, Seoul, Korea ¹⁰ Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea ¹¹ Department of Cardiovascular Medicine, Chonnam National University Medical School, Gwangju, Korea ¹² Division of Cardiology, Catholic University of Daegu, Daegu, Korea

10:50-11:05
No: 111
[620160]

English Session Label adherence of non-vitamin K antagonist oral anticoagulants and clinical outcomes in patients with atrial fibrillation: A nationwide cohort study

[Speaker] Hee Tae YU
Hee Tae Yu¹, Pil-Sung Yang², Tae-Hoon Kim¹, Eunsun Jang¹, Jae-Sun Uhm¹, Jong-Youn Kim¹, Hui-Nam Pak¹, Moon-Hyoung Lee¹, Boyoung Joung¹, Gregory Y.H. Lip^1,3
¹Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea, ²Department of Cardiology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea, ³Institute of Cardiovascular Sciences, University of Birmingham, United Kingdom, and Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

11:05-11:20
No: 112
[620528]

English Session Oral anticoagulation for low-risk non-valvular atrail fibrillation patients with 1 risk factor of the CHA2DS2-VASc score:A nationwide population-based study

[Speaker] Sun Young CHOI
Sun Young Choi¹, Moo Hyun Kim², Soo Jin Kim², Kwang Min Lee², Seong Woo Kim²,Jong Sung Park², Tae-Ho Park², Kyungil Park²
¹Depratment of Biomedical Laboratory Science, Daegu Health College, Deagu, South Korea, ²Departemtn of Cardiology, College of Medicine, Dong-A University hospital, Busan, Sounth Korea

11:20-11:35
No: 113
[620022]

English Session What is standard dose of rivaroxaban in Korean patients with atrial fibrillation: 20ms vs. 15mg? Off label dose reduction of rivaroxaban should be avoided

[Speaker] Ki Hong
Ki Hong Lee¹, Hyung Wook Park¹, Hyung Ki Jeong¹, Nuri Lee¹, Nam Sik Yoon¹, Young Keun Ahn¹, Myung Ho Jeong¹, Jong Chun Park¹, Jeong Gwan Cho¹
1 Department of Cardiovascular Medicine, Chonnam National University Hospital, Gwangju, Korea

11:35-11:50
No: 114
[620562]

English Session Impact of VKORC1, CYP2C9 and CYP4F2 polymorphisms on optimal warfarin dose in Koreans: Ethnicity matters?

[Speaker] Jia Xin LI
Jia Xin Li¹, Moo Hyun Kim¹, Kai Song¹, Soo Jin Kim¹, Gwang Min Lee¹
Department of Cardiology Dong-A University Hospital, Korea

일정표 및 초록검색